streptavidin coated scintillation microplates (Revvity)
91
Structured Review
Revvity
streptavidin coated scintillation microplates
Streptavidin Coated Scintillation Microplates, supplied by Revvity, used in various techniques. Bioz Stars score: 91/100, based on 39 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flashplate/FlashPlate+Plus%2C+Streptavidin+96-well+scintillant+coated+microplate%2C+5+Plates/pmc10360169-199-27-34
Average 91 stars, based on 39 article reviews
Streptavidin Coated Scintillation Microplates, supplied by Revvity, used in various techniques. Bioz Stars score: 91/100, based on 39 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flashplate/FlashPlate+Plus%2C+Streptavidin+96-well+scintillant+coated+microplate%2C+5+Plates/pmc10360169-199-27-34
Average 91 stars, based on 39 article reviews
streptavidin coated scintillation microplates - by Bioz Stars,
2026-11
91/100 stars
Images
Related Articles
Incubation:Article Title: Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases Article Snippet: Class I phosphoinositide 3-kinases (PI3Ks), particularly PI3Kc, have become attractive drug targets for inflammatory and autoimmune disorders such as rheumatoid arthritis.. Herein, we describe the synthesis and the structure–activity relationships (SAR) of a series of 2-amino-5-oxadiazolyl thiazoles, culminating in the identification of 8j (TASP0415914), an orally potent inhibitor of phosphoinositide 3-kinase c (PI3Kc).. TASP0415914 demonstrated good potency in a cell-based assay and, furthermore, exhibited in vivo efficacy in a collagen induced arthritis (CIA) model in mice after oral administration. Article Title: Discovery and optimization of a series of 2-aminothiazole-oxazoles as potent phosphoinositide 3-kinase γ inhibitors Article Snippet: Article history: Received 11 July 2012 Revised 2 October 2012 Accepted 5 October 2012 Available online 12 October 2012 Article Title: Design, Synthesis and Biological Evaluation of 4-Amino- N -(4-aminophenyl)benzamide Analogues of Quinoline-Based SGI-1027 as Inhibitors of DNA Methylation Article Snippet: [ ] The reaction was performed in a total reaction volume of 10 μL in low-volume nonbinding surface (NBSTM) 384-well microplates (Corning Inc.), containing test compound (up to 1 % DMSO), 1 μ m of a S -adenosyl- l -methionine (SAM)/[methyl-3H]SAM (3 TBq mmol −1 , PerkinElmer) mix in a ratio of 3:1 (isotopic dilution 1*:3), 0.3 μ m of biotinylated hemimethylated DNA duplex (5′-GAT mC GC mC GATG mC G mC GAAT mC G mC GAT mC GATG mC GAT-3′ and BIOT-5′-ATCGCATCGATCGCGATTCGCGCATCGGCGATC-3′), and 90 n m of DNMT1 in methylation buffer (20 m m HEPES (pH 7.2), 1 m m EDTA, 50 m m KCl, 25 μg mL −1 bovine serum albumin). .. The reaction was incubated at 37 °C for 2 h, then an aliquot (8 μL) was transferred into a Article Title: Design, Synthesis and Biological Evaluation of 4-Amino-N-(4-aminophenyl)benzamide Analogues of Quinoline-Based SGI-1027 as Inhibitors of DNA Methylation Article Snippet: [22] The reaction was performed in a total reaction volume of 10 mL in low-volume nonbinding surface (NBSTM) 384-well microplates (Corning Inc.), containing test compound (up to 1 % DMSO), 1 mm of a S-adenosyl-lmethionine (SAM)/[methyl-3H]SAM (3 TBq mmol 1, PerkinElmer) mix in a ratio of 3:1 (isotopic dilution 1*:3), 0.3 mm of biotinylated hemimethylated DNA duplex (5’-GATmCGCmCGATGmCGmCGAATmCGmCGATmCGATGmCGAT-3’ and BIOT-5’-ATCGCATCGATCGCGATTCGCGCATCGGCGATC-3’), and 90 nm of DNMT1 in methylation buffer (20 mm HEPES (pH 7.2), 1 mm EDTA, 50 mm KCl, 25 mg mL 1 bovine serum albumin). .. The reaction was incubated at 37 8C for 2 h, then an aliquot (8 mL) was transferred into a Article Title: Identification and optimization of hydrazone-gallate derivatives as specific inhibitors of DNA methyltransferase 3A. Article Snippet: 2016 DNA methylation is the most studied epigenetic event.. Since the methylation profile of the genome is widely modified in cancer cells, DNA methyltransferases are the target of new anticancer therapies.. Nucleosidic inhibitors suffer from toxicity and chemical stability, while non-nucleosidic inhibitors lack potency. |